Stoke Therapeutics, Inc. (STOK)
33.96
+0.77
(+2.32%)
USD |
NASDAQ |
Mar 16, 16:00
33.11
-0.85
(-2.50%)
After-Hours: 20:00
Stoke Therapeutics Total Liabilities (Quarterly) : 52.16M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen, Inc. | 11.18B |
| Krystal Biotech, Inc. | 114.23M |
| Scholar Rock Holding Corp. | 158.78M |
| Vertex Pharmaceuticals, Inc. | 7.477B |
| Zymeworks, Inc. | 78.03M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 360.26M |
| Shareholders Equity (Quarterly) | 308.10M |
| Debt to Equity Ratio | 0.0155 |
| Current Ratio | 6.529 |
| Net Debt Paydown Yield | 0.02% |